These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27212474)

  • 1. A Prospective Comparison of Younger and Older Patients' Preferences for Adjuvant Chemotherapy and Hormonal Therapy in Early Breast Cancer.
    Hamelinck VC; Bastiaannet E; Pieterse AH; de Glas NA; Portielje JE; Merkus JW; den Hoed ID; van de Velde CJ; Liefers GJ; Stiggelbout AM
    Clin Breast Cancer; 2016 Oct; 16(5):379-388. PubMed ID: 27212474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferred and Perceived Participation of Younger and Older Patients in Decision Making About Treatment for Early Breast Cancer: A Prospective Study.
    Hamelinck VC; Bastiaannet E; Pieterse AH; van de Velde CJH; Liefers GJ; Stiggelbout AM
    Clin Breast Cancer; 2018 Apr; 18(2):e245-e253. PubMed ID: 29275105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' preferences for surgical and adjuvant systemic treatment in early breast cancer: a systematic review.
    Hamelinck VC; Bastiaannet E; Pieterse AH; Jannink I; van de Velde CJ; Liefers GJ; Stiggelbout AM
    Cancer Treat Rev; 2014 Sep; 40(8):1005-18. PubMed ID: 24986544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Recurrence or Contralateral Breast Cancer More than 5 Years After Diagnosis of Hormone Receptor-Positive Early-Stage Breast Cancer.
    Wilson S; Speers C; Tyldesley S; Chia S; Kennecke H; Ellard S; Lohrisch C
    Clin Breast Cancer; 2016 Aug; 16(4):284-90. PubMed ID: 26705158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapies for very young women with early stage breast cancer.
    Freedman RA; Partridge AH
    Breast; 2011 Oct; 20 Suppl 3():S146-9. PubMed ID: 22015283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer.
    Sanft T; Aktas B; Schroeder B; Bossuyt V; DiGiovanna M; Abu-Khalaf M; Chung G; Silber A; Hofstatter E; Mougalian S; Epstein L; Hatzis C; Schnabel C; Pusztai L
    Breast Cancer Res Treat; 2015 Dec; 154(3):533-41. PubMed ID: 26578401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Navigating the Challenges of Endocrine Treatments in Premenopausal Women with ER-Positive Early Breast Cancer.
    Colleoni M; Munzone E
    Drugs; 2015 Aug; 75(12):1311-21. PubMed ID: 26177891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy in elderly women with breast cancer: patients' perspectives on information giving and decision making.
    Harder H; Ballinger R; Langridge C; Ring A; Fallowfield LJ
    Psychooncology; 2013 Dec; 22(12):2729-35. PubMed ID: 23813806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario.
    Levine MN; Julian JA; Bedard PL; Eisen A; Trudeau ME; Higgins B; Bordeleau L; Pritchard KI
    J Clin Oncol; 2016 Apr; 34(10):1065-71. PubMed ID: 26598746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
    Foukakis T; von Minckwitz G; Bengtsson NO; Brandberg Y; Wallberg B; Fornander T; Mlineritsch B; Schmatloch S; Singer CF; Steger G; Egle D; Karlsson E; Carlsson L; Loibl S; Untch M; Hellström M; Johansson H; Anderson H; Malmström P; Gnant M; Greil R; Möbus V; Bergh J;
    JAMA; 2016 Nov; 316(18):1888-1896. PubMed ID: 27825007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
    Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
    Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' preferred and perceived roles in making decisions about adjuvant chemotherapy for non-small-cell lung cancer.
    Moth E; McLachlan SA; Veillard AS; Muljadi N; Hudson M; Stockler MR; Blinman P
    Lung Cancer; 2016 May; 95():8-14. PubMed ID: 27040845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
    Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer.
    Cadoo KA; Morris PG; Cowell EP; Patil S; Hudis CA; McArthur HL
    Clin Breast Cancer; 2016 Dec; 16(6):487-493. PubMed ID: 27622751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant radiation with hormonal therapy is associated with improved survival in men with pathologically involved lymph nodes after radical surgery for prostate cancer.
    Wong AT; Schwartz D; Osborn V; Safdieh J; Weiner J; Schreiber D
    Urol Oncol; 2016 Dec; 34(12):529.e15-529.e20. PubMed ID: 27443637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment recommendations for older women with breast cancer: A survey among surgical, radiation and medical oncologists.
    Hamelinck VC; Stiggelbout AM; van de Velde CJH; Liefers GJ; Bastiaannet E
    Eur J Surg Oncol; 2017 Jul; 43(7):1288-1296. PubMed ID: 28258786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial.
    ; Blinman P; Mileshkin L; Khaw P; Goss G; Johnson C; Capp A; Brooks S; Wain G; Kolodziej I; Veillard AS; O'Connell R; Creutzberg CL; Stockler MR
    Br J Cancer; 2016 Nov; 115(10):1179-1185. PubMed ID: 27764842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on adjuvant systemic therapy for elderly patients with early breast cancer.
    Jerzak KJ; Desautels DN; Pritchard KI
    Expert Opin Pharmacother; 2016 Oct; 17(14):1881-8. PubMed ID: 27539883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.